Factorial trial for treating sleepy overweight or obese sleep apnea patients who cannot use standard treatments comparing hypocaloric diet with high protein/ low glycemic index diet for fat mass reduction and simultaneously comparing armodafinil with placebo for improving simulated driving ability and neuro-behavioural functioning

Trial Profile

Factorial trial for treating sleepy overweight or obese sleep apnea patients who cannot use standard treatments comparing hypocaloric diet with high protein/ low glycemic index diet for fat mass reduction and simultaneously comparing armodafinil with placebo for improving simulated driving ability and neuro-behavioural functioning

Completed
Phase of Trial: Phase II/III

Latest Information Update: 18 May 2018

At a glance

  • Drugs Armodafinil (Primary)
  • Indications Obesity; Sleep apnoea syndrome
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms DEAR
  • Most Recent Events

    • 18 May 2018 Primary endpoint (loss of fat mass (grams) as measured by a DXA scan at 12 months.Timepoint: Baseline, 6 months) has been met, according to results published in the American Journal of Respiratory and Critical Care Medicine.
    • 18 May 2018 Primary endpoint has (Improvement in simulated driving ability quantified by standard deviation in lane position as measured by the AusEd driving simulator in the last 30 minutes of a 90 minute drive.Timepoint: Baseline, 6 months) not been met, according to results published in the American Journal of Respiratory and Critical Care Medicine.
    • 18 May 2018 Primary endpoint (Primary outcome for pharmaceutical trial: Improvement in simulated driving ability quantified by standard deviation in lane position as measured by the AusEd driving simulator in the last 30 minutes of a 90 minute drive.) has been met, according to results published in the American Journal of Respiratory and Critical Care Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top